Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease

BACKGROUND/AIMS: Patients with inflammatory bowel disease (IBD) are diagnosed with ankylosing spondylitis (AS) often. However, the disease course of patients with both IBD and AS is not well understood. This study aims to evaluate the effect of concomitant AS on IBD outcomes. METHODS: Among the 4,72...

Descripción completa

Detalles Bibliográficos
Autores principales: Jun, Yu Kyung, Yoon, Hyuk, Koh, Seong-Joon, Kim, A Hyeon, Kim, Kwang Woo, Park, Jun Won, Lee, Hyun Jung, Kang, Hyoun Woo, Im, Jong Pil, Park, Young Soo, Kim, Joo Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169522/
https://www.ncbi.nlm.nih.gov/pubmed/35929093
http://dx.doi.org/10.5217/ir.2022.00057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169522/
https://www.ncbi.nlm.nih.gov/pubmed/35929093
http://dx.doi.org/10.5217/ir.2022.00057

Ejemplares similares